Evidence map›Paper›PMID 39599765›Full record

ArticleViruses2024

Circulation and Codetections of Influenza Virus, SARS-CoV-2, Respiratory Syncytial Virus, Rhinovirus, Adenovirus, Bocavirus, and Other Respiratory Viruses During 2022-2023 Season in Latvia.

Inara Kampenusa, Baiba Niedre-Otomere, Julija Trofimova, Ilva Pole, Gatis Pakarna, Oksana Savicka, Sergejs Nikisins

Abstract read
In one paragraph

Article in Viruses, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Inara KampenusaNational Microbiology Reference Laboratory of Latvia, Laboratory "Latvian Centre of Infectious Diseases" Laboratory Service, Riga East University Hospital, Linezera Street 3, LV-1006 Riga, Latvia.ORCID 0000-0001-8053-3525
Baiba Niedre-OtomereNational Microbiology Reference Laboratory of Latvia, Laboratory "Latvian Centre of Infectious Diseases" Laboratory Service, Riga East University Hospital, Linezera Street 3, LV-1006 Riga, Latvia.
Julija TrofimovaNational Microbiology Reference Laboratory of Latvia, Laboratory "Latvian Centre of Infectious Diseases" Laboratory Service, Riga East University Hospital, Linezera Street 3, LV-1006 Riga, Latvia.
Ilva PoleNational Microbiology Reference Laboratory of Latvia, Laboratory "Latvian Centre of Infectious Diseases" Laboratory Service, Riga East University Hospital, Linezera Street 3, LV-1006 Riga, Latvia.ORCID 0000-0001-8472-8178
Gatis PakarnaNational Microbiology Reference Laboratory of Latvia, Laboratory "Latvian Centre of Infectious Diseases" Laboratory Service, Riga East University Hospital, Linezera Street 3, LV-1006 Riga, Latvia.
Oksana SavickaNational Microbiology Reference Laboratory of Latvia, Laboratory "Latvian Centre of Infectious Diseases" Laboratory Service, Riga East University Hospital, Linezera Street 3, LV-1006 Riga, Latvia.ORCID 0000-0003-0047-3644
Sergejs NikisinsNational Microbiology Reference Laboratory of Latvia, Laboratory "Latvian Centre of Infectious Diseases" Laboratory Service, Riga East University Hospital, Linezera Street 3, LV-1006 Riga, Latvia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This retrospective study analysed the routine data obtained by multiplex real-time RT-qPCR methods for respiratory virus detection. A total of 4814 respiratory specimens collected during 1 September 2022-31 August 2023 were included in the study. A total of 38% of the specimens were positive for at least one target, with the incidence maximum (82%) for the small children (age group 0-4 years). The five dominant virus groups were rhinovirus (RV, 12%), influenza virus A (IAV, 7%), adenovirus (AdV, 6%), respiratory syncytial virus (RSV, 5%), and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, 5%). The specimens with multi-detections represented 19% of the positives, unevenly distributed (n = 225, 56, 43, 24) among the age groups 0-4, 5-14, 15-64, and 65< years, respectively. The dominant virus groups in multi-positive specimens were RV (53%), AdV (43%), and bocavirus (BoV, 35%)-in mutual pairs as well as all three together-followed by RSV (21%), and IAV (15%). Our study focused on the specimens with codetections and provides an insight into the variety of the respiratory virus interactions in Latvia during the first year since pandemic-related social restriction measures were eased. The observations also emphasise the need to consider the differentiation between rhinoviruses and enteroviruses, especially for the youngest patients in the age group 0-4.

Indexed as

AdenoviridaeRespiratory Tract InfectionsRhinovirusAdolescentAdultAgedBocavirusChildChild, PreschoolCoinfectionCOVID-19FemaleHumansInfantInfant, NewbornLatviaadenovirusbocavirusenterovirusinfluenza virusespatients’ median agerespiratory syncytial virusrespiratory virusesrhinovirusSARS-CoV-2

Identifiers

PMID39599765
PMCPMC11598885

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.